Drug resistance in Indian visceral leishmaniasis

Tropical Medicine and International Health

Volumn 6, Issue 11, 2001, Pages 849-854

  Sundar, Shyam ^a,b  

^a BANARAS HINDU UNIVERSITY   (India)

^b NONE   (India)

Author keywords

Antimony; Drug resistance; Kala azar; Visceral leishmaniasis

Indexed keywords

AMPHOTERICIN B; ANTILEISHMANIAL AGENT; ANTIMONY DERIVATIVE; LIPID; MILTEFOSINE; PAROMOMYCIN; PENTAMIDINE; SITAMAQUINE;

DISEASE TREATMENT; DRUG PRESCRIBING; DRUG RESISTANCE; LEISHMANIASIS;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DISEASE TRANSMISSION; DRUG COST; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG RESPONSE; DRUG SAFETY; DRUG USE; ENDEMIC DISEASE; GEOGRAPHIC DISTRIBUTION; HUMAN; IN VITRO STUDY; INDIA; LEISHMANIA DONOVANI; NONHUMAN; PARASITE ISOLATION; REVIEW; TREATMENT FAILURE; VISCERAL LEISHMANIASIS;

AMINOQUINOLINES; AMPHOTERICIN B; ANTIMONY; ANTIPROTOZOAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; GEOGRAPHY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INDIA; LEISHMANIASIS, VISCERAL; PAROMOMYCIN; PENTAMIDINE; PHOSPHORYLCHOLINE; TREATMENT OUTCOME;

INDIA;

LEISHMANIA DONOVANI; NASO HEXACANTHUS; PROTOZOA;

EID: 0034780949     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.2001.00778.x     Document Type: Review

References (29)

1. Epidemiology of visceral leishmaniasis in India
2. Treatment of visceral leishmaniasis unresponsive to pentamidine with amphotericin B
3. Experience with amphotericin B in sodium stibogluconate-unresponsive cases of visceral leishmaniasis in North Bihar
4. Evaluation of diamidine compounds (pentamidine isethionate) in the treatment of resistant cases of kala-azar occurring in North Bihar, India
5. Changing response to diamidine compounds in cases of kala-azar unresponsive to antimonials
6. Therapeutic use of sodium stibogluconate in kala-azar from some hyperendemic districts of N. Bihar, India
7. Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India
8. Miltefosine, an oral agent for the treatment of Indian visceral leishmaniasis
9. Evidence that the high incidence of treatment failure in kala-azar is due to the emergence of antimony resistant strains of Leshmania donovani
10. Amphotericin vs. sodium stibogluconate in first-line treatment of Indian kala-azar
11. The treatment of kala-azar. New approach to an old problem
12. Phase 2 efficacy trial of an oral 8-aminoquinoline (WR6026) for treatment of visceral leishmaniasis
13. Cure of antimony-unresponsive Indian visceral leishmaniasis with amphotericin B lipid complex
14. Clinico-epidemiological study of drug resistance in Indian kala-azar
15. Immunochemo-therapy for a systemic intracellular infection: Accelerated response using interferon-γ in visceral leishmaniasis
16. Response to interferon-γ plus pentavalent antimony in Indian visceral leishmaniasis
17. Short-course, low dose amphotericin B lipid complex therapy for visceral leishmaniasis unresponsive to antimony
18. A cluster of severe antimony cardiotoxicity in kala-azar due to high osmolality lot
19. Trial of oral miltefosine treatment for visceral leishmaniasis
20. Failure of pentavalent antimony in visceral leishmaniasis in India: Report from the center of the Indian epidemic
21. Short-course oral miltefosine treatment for visceral leishmaniasis
22. Low dose liposomal amphotericin B (AmBisome) in refractory Indian visceral leishmaniasis - A multicenter study
23. Comparison of regimens of treatment with sodium stibogluconate in kala-azar
24. Rationalisation of regimens of treatment of kala-azar with sodium stibogluconate in India: A randomized study
25. Evaluation of efficacy of longer duration of therapy of fresh cases of kala-azar with sodium stibogluconate
26. Comparison of regimens of treatment of antimony-resistant kala-azar patients: A randomized study
27. The leishmaniases: Report of a WHO expert committee
28. The control of leishmaniases: Report of an expert committee